2021
DOI: 10.3390/ijms22073515
|View full text |Cite
|
Sign up to set email alerts
|

Reconstruction of Critical Nerve Defects Using Allogenic Nerve Tissue: A Review of Current Approaches

Abstract: Regardless of the nerve defect length, nerve injury is a debilitating condition for the affected patient that results in loss of sensory and motor function. These functional impairments can have a profound impact on the patient’s quality of life. Surgical approaches for the treatment of short segment nerve defects are well-established. Autologous nerve transplantation, considered the gold standard, and the use of artificial nerve grafts are safe and successful procedures for short segment nerve defect reconstr… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
30
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 28 publications
(31 citation statements)
references
References 88 publications
0
30
0
1
Order By: Relevance
“…The success of acellular allografts in the case of peripheral nerve reconstruction is well-documented 4–10 . The use of PNAs in the repair of cranial nerve injuries, however, has significantly less data.…”
Section: Discussionmentioning
confidence: 99%
See 3 more Smart Citations
“…The success of acellular allografts in the case of peripheral nerve reconstruction is well-documented 4–10 . The use of PNAs in the repair of cranial nerve injuries, however, has significantly less data.…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, the acellular nature of these cadaveric grafts raises the concern for their ability to regenerate in the cytotoxic therapy such as radiation. In such a context, the efficacy of these grafts remains unclear, and the application of an autografting technique as described above may be more heavily favored 9–10 . Given the numerous potential benefits, further investigation regarding the clinical application of nerve allograft to nonperipheral nerve reconstruction is warranted.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Another product developed by Integra Life Sciences (Plainsboro, NJ) and composed of semi-permeable Type I collagen is marketed under name Neuragen. A practical limitation of tubular collagen products is their tendency to collapse and kink and their potential for scarring ( Kornfeld et al, 2021a ).…”
Section: Introductionmentioning
confidence: 99%